Tumor classified as subtype 1 had higher mutation rate, HRD score and pathological tumor infiltrating lymphocyte score, lower BRCA1 expression and were less likely from older patients or those with higher body mass index (BMI; P ≤ 0.05; Fig. 3b). Here, BRCA1 is linked to neoplasm.